SAR445256 (KY1044) in combination with atezolizumab in patients (pts) with recurrent/metastatic head and neck squamous cell carcinoma (HNSCC)
Patel, M. Ascierto, P. A. Thistlethwaite, Fiona C Adkins, D. R. Villaflor, V. M. Galizia, D. Calabro, L. Di Maio, M. D'Ambrosio, C. Bertolini, A.
Patel, M.
Ascierto, P. A.
Thistlethwaite, Fiona C
Adkins, D. R.
Villaflor, V. M.
Galizia, D.
Calabro, L.
Di Maio, M.
D'Ambrosio, C.
Bertolini, A.
Citations
Altmetric:
Abstract
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Patel M, Ascierto PA, Thistlethwaite F, Adkins DR, Villaflor VM, Galizia D, et al. SAR445256 (KY1044) in combination with atezolizumab in patients (pts) with recurrent/metastatic head and neck squamous cell carcinoma (HNSCC). Annals of Oncology. 2022 Sep;33(7):S864-S5. PubMed PMID: WOS:000866211600695.